| Literature DB >> 33089354 |
B A M Larsson1, L Johansson1,2, H Johansson1,3, K F Axelsson1,4, N Harvey5,6, L Vandenput3,7, P Magnusson8, E McCloskey9,10, E Liu3, J A Kanis3,9, D Sundh1, M Lorentzon11,12,13.
Abstract
The timed up and go (TUG) test measures physical performance and predicts falls in the elderly. In older women, TUG time predicts the risk of major osteoporotic fracture and hip fracture independently of clinical risk factors and bone mineral density, and has a substantial impact on fracture probabilities.Entities:
Keywords: Clinical risk factors and bone mineral density; Fracture risk; The timed up and go test
Mesh:
Year: 2020 PMID: 33089354 PMCID: PMC7755867 DOI: 10.1007/s00198-020-05681-w
Source DB: PubMed Journal: Osteoporos Int ISSN: 0937-941X Impact factor: 4.507
Fig. 1a The relationship between timed up and go (TUG) time and incidence of major osteoporotic fracture (MOF). Incidence and 95% confidence intervals of MOF according to TUG (seconds) is described per 100,000 person-years. b The relationship between timed up and go (TUG) time and incidence of hip fracture. Incidence and 95% confidence intervals of hip fracture according to TUG (seconds) is described per 100,000 person-years
Characteristics of older women with timed up and go (TUG) ≤ 12 s and > 12 s
| TUG ≤ 12 s ( | TUG > 12 s ( | ||
|---|---|---|---|
| Age (years) | 77.7 ± 1.6 | 78.2 ± 1.6 | < 0.001 |
| Height (cm) | 162.0 ± 5.7 | 160.2 ± 6.5 | < 0.001 |
| Weight (kg) | 68.1 ± 11.5 | 74.4 ± 15.3 | < 0.001 |
| Body mass index (kg/m2) | 25.9 ± 4.2 | 29.0 ± 5.5 | < 0.001 |
| FN aBMD (g/cm2) | 0.66 ± 0.10b | 0.65 ± 0.12 | 0.041 |
| Hip aBMD (g/cm2) | 0.80 ± 0.11b | 0.78 ± 0.13g | < 0.001 |
| Lumbar spine aBMD (g/cm2) | 0.94 ± 0.16f | 0.98 ± 0.18h | < 0.001 |
| FRAX MOF w/o BMD (%) | 30.8 ± 12 | 30.3 ± 12 | 0.50 |
| FRAX hip fracture w/o BMD (%) | 18.0 ± 12 | 16.9 ± 12 | 0.12 |
| FRAX MOF with BMD (%) | 22.7 ± 12 | 25.1 ± 13 | < 0.01 |
| FRAX hip fracture with BMD (%) | 10.8 ± 11 | 12.3 ± 12 | < 0.01 |
| PASE | 108.4 ± 50.0b | 67.9 ± 41.6g | < 0.001 |
| PCS | 46.6 ± 10.1 | 32.9 ± 9.4g | < 0.001 |
| MCS | 54.0 ± 8.9 | 49.7 ± 11.9g | < 0.001 |
| Calcium intake (from dairy products), mg/day | 397 ± 362 | 313 ± 381 | < 0.01 |
| Fall accident within the last year, % | 26.7i | 53.4j | < 0.001 |
| Self-reported prior fracture, % φ | 35.8 k | 45.7l | < 0.001 |
| Parental history of hip fracture, % | 17.5m c | 17.3n | 0.922 |
| Current smoking, % | 5.0Ϯ | 6.5o | 0.263 |
| Excessive alcohol consumption, % χ | 0.6p | 0.3q | 1.000e |
| Blood biochemistry (serum) | |||
| Creatinine (μmol/L) | 76.7 ± 15.7Ϫ | 85.6 ± 32.5g | < 0.001 |
| Calcium (mmol/L) | 2.47 ± 0.1Ϫ | 2.49 ± 0.1g | 0.016 |
| 25-Hydroxyvitamin D3 (nmol/L) | 62.5 ± 21.0Ϫ | 60.6 ± 23.4g | 0.143 |
| PTH (pmol/L) | 4.90 ± 2.0 | 6.30 ± 3.6 | < 0.001 |
| Medications | |||
| Glucocorticoid use, % ψ | 3.4r | 2.8s | 0.564 |
| Osteoporosis medication, % ω | 9.7 t | 17.2u | < 0.001 |
| Medical history | |||
| Rheumatoid arthritis, % | 3.4r | 7.5v | < 0.001 |
| Hyperthyroidism, % | 4.8w | 7.9x | 0.020e |
| Osteoporosis, % ϊ | 18.7y | 34.6z | < 0.001 |
| Hypertension, % | 51.5α | 59.2β | 0.012 |
| Stroke, % | 5.8γ | 17.5 u | < 0.001 |
| Myocardial infarction, % | 4.1δ | 11.3ε | < 0.001 |
| Angina, % | 4.6ζ | 12.7η | < 0.001 |
| Heart failure, % | 7.8θ | 18.2ι | < 0.001 |
| Parkinson’s disease, % | 0.52κ | 3.4λ | < 0.001e |
| Type 2 diabetes, % | 8.9μ d | 17.1u | < 0.001 |
| Chronic bronchitis, asthma, emphysema, % | 9.2π | 16.8n | < 0.001 |
| Cancer, % | 20.6ρ | 21.2ς | 0.811 |
| Glaucoma, % | 8.0σ | 8.9τ | 0.579 |
Values are presented as mean ± standard deviation for continuous variables and as percentage and number for categorical variables. Significance was defined by a p value < 0.05 and significant values are italicized
aCategorical variables χ2 test; b2699; c2673; d2709; eFisher’s exact test; f2693; g292; h285; i724; j156; k967; Ϯ135; l133; m469; n49; o19; p16; q1; r92; s8; t262; u50; v22; w129; x23; y506; z101; Ϫ2710; α1395; β173; γ157; δ110; ε33; ζ125; η37; θ211; ι53; κ14; λ10; μ242; π248; ρ559; ς62; σ216, τ26, φafter 50 years of age, fractures of the skull and face are excluded, χ21 or more units per week; ψdaily oral treatment with at least 5 mg prednisolone (or equivalent) for 3 months or more ever; ωcurrent treatment with bisphosphonates, teriparatide, or denosumab; ϊ Self-reported—been diagnosed with osteoporosis, TUG timed up and go, FN femoral neck, PASE Physical Activity Scale for the Elderly, MCS Mental health Component Scale, PCS Physical Health Component Scale
Associations between TUG time > 12 s and fracture risk in older women
| TUG ≤ 12 s ( | TUG > 12 s ( | |
|---|---|---|
| Nonvertebral fracturea | ||
| No. (%) | 262 (9.7) | 52 (17.7) |
| Rate per 1000 person-years | 28.6 | 54.5 |
| Time at risk, median (IQR), years | 3.4 (1.68) | 3.3 (1.54) |
| HR (95% CI) | ||
| Adjusted for age, height, weight (model 1) | 1 [Reference] | 2.09 [1.53–2.84] |
| + Clinical risk factors (model 2) | 1 [Reference]b | 1.61 [1.16–2.23]c |
| + FN BMD (model 3) | 1 [Reference]d | 1.45 [1.04–2.02]e |
| Major osteoporotic fracture | ||
| No. (%) | 271 (10.0) | 64 (21.8) |
| Rate per 1000 person-years | 29.7 | 67.9 |
| Time at risk, median (IQR), years | 3.4 (1.68) | 3.3 (1.62) |
| HR (95% CI) | ||
| Adjusted for age, height, weight (model 1) | 1 [Reference] | 2.39 [1.80–3.18] |
| + Clinical risk factors (model 2) | 1 [Reference]b | 1.96 [1.45–2.65]c |
| +FN BMD (model 3) | 1 [Reference]d | 1.76 [1.30–2.40]e |
| Hip fracture | ||
| No. (%) | 51 (1.9) | 15 (5.1) |
| Rate per 1000 person-years | 5.3 | 14.6 |
| Time at risk, median (IQR), years | 3.6 (1.28) | 3.5 (1.61) |
| HR (95% CI) | ||
| Adjusted for age, height, weight (model 1) | 1 [Reference] | 2.96 [1.62–5.40] |
| + Clinical risk factors (model 2) | 1 [Reference]b | 2.66 [1.40–5.08]c |
| + FN BMD (model 3) | 1 [Reference]d | 1.93 [1.00–3.71]e |
Associations were studied using Cox proportional hazard models. Hazard ratios (HR) and 95% confidence intervals (CI) are presented. Model 1: adjusted for age, height, and weight. Model 2: adjusted for age, height, weight, and clinical risk factors included in FRAX (previous fracture, family history of hip fracture, current smoking, oral glucocorticoid use, rheumatoid arthritis, excessive alcohol intake), osteoporosis medication, and history of falls. Major osteoporotic fractures included fractures of the spine, hip, forearm, and proximal humerus. Model 3: adjusted all covariates used in model 2 with the addition of FN BMD
aExcluding fractures of the skull, face, hand and foot; b2661; c279; d2649; e278
Fig. 210-year (a, b) and 4-year (c, d) probability of major osteoporotic fracture according to femoral neck BMD and TUG time. a, b 10-year probability of a major osteoporotic fracture (MOF) in a 75-year-old (a) or 80-year-old (b) woman according to T-score of femoral neck BMD. The symbol (closed circle) denote probabilities calculated without TUG and the lines the range of probabilities with TUG > 12 and TUG ≤ 12 using the model incorporating TUG. In the used model, BMI is set to 26 kg/m2, previous fracture to yes, but all other clinical risk factors set to no. c, d 4-year probability of a major osteoporotic fracture (MOF) in a 75-year-old (c) or 80-year-old (d) woman according to T-score of femoral neck BMD. The symbol (closed circle) denote probabilities calculated without TUG and the lines the range of probabilities with TUG > 12 and TUG ≤ 12 using the model incorporating TUG. In the used model, BMI is set to 26 kg/m2, previous fracture to yes, but all other clinical risk factors set to no
Fig. 3The ratio between the 4-year probability of major osteoporotic fracture with and without considering TUG time is dependent on femoral neck BMD. The ratio between the 4-year probability of major osteoporotic fracture with TUG > 12 s and without considering TUG, shown for women 75 and 80 years old according to femoral neck BMD T-score. In the used model, BMI is set to 26 kg/m2, previous fracture to yes, but all other clinical risk factors set to no